Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study.

Darpo B, Nedelman J, Bruning-Barry R, Hickman D, Kleiman R, Lombardi A, Xue H

Open source

DOI
10.1128/aac.01273-25
Published
2026 Mar 4
Container
Antimicrobial agents and chemotherapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/aac.01273-25,
  title = {Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study.},
  author = {Darpo B and Nedelman J and Bruning-Barry R and Hickman D and Kleiman R and Lombardi A and Xue H},
  year = {2026},
  journal = {Antimicrobial agents and chemotherapy},
  doi = {10.1128/aac.01273-25},
  url = {https://doi.org/10.1128/aac.01273-25}
}

RIS

TY  - JOUR
TI  - Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study.
AU  - Darpo B
AU  - Nedelman J
AU  - Bruning-Barry R
AU  - Hickman D
AU  - Kleiman R
AU  - Lombardi A
AU  - Xue H
PY  - 2026
JO  - Antimicrobial agents and chemotherapy
DO  - 10.1128/aac.01273-25
UR  - https://doi.org/10.1128/aac.01273-25
ER  - 

APA

B, D., J, N., R, B., D, H., R, K., A, L., & H, X. (2026). Cardiodynamic evaluation of sorfequiline (TBAJ-876): results from a first-in-human study.. Antimicrobial agents and chemotherapy. https://doi.org/10.1128/aac.01273-25

Source records